Skip to content

InvestorsNASDAQ: ANIX

Stock SEC Filings

Back to anixa.com

Corporate deck Contact Investor FAQs

Loading…

NASDAQ: ANIXBack to anixa.com

Company

Overview
Leadership
Governance
Contact

Investors

Press Releases
Events & Webcasts
Stock Information
SEC Filings

Resources

Presentations
Email Alerts
Investor FAQs

Anixa Biosciences, Inc. uses its investor relations website as a recognized channel for disclosing material, non-public information and for complying with its disclosure obligations under Regulation FD. Investors should monitor this site, along with the company's press releases, SEC filings, and public conference calls and webcasts.

© 2026 Anixa Biosciences, Inc.Privacy Terms Accessibility

Site by Front Yard and Crescendo Communications

We use cookies to power embedded market data and to remember your alert preferences. You can decline non-essential cookies.

SEC filings

View company page on EDGAR

All filings Annual Quarterly Current (8-K)Proxy Registration Insider buying/selling

Year

2011

All years 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 2007 2006 2005 2004

FiledFormReporting personTransactionAmount

May 27, 2011
4
Larounis George P
Director
- MOption exercise+60,000
- MOption exercise−60,000
↗
May 27, 2011
4
Krusos Denis A
Director, Chief Executive Officer
- MOption exercise+500,000
- MOption exercise−500,000
↗
Feb 10, 2011
4
Herms Henry P
Director, Chief Financial Officer
- POpen-market purchase+280,000
- POpen-market purchase+280,000
↗
Feb 10, 2011
4
Krusos Denis A
Director, Chief Executive Officer
- POpen-market purchase+1,400,000
- POpen-market purchase+1,400,000
↗
Feb 10, 2011
4
Larounis George P
Director
- POpen-market purchase+280,000
- POpen-market purchase+280,000
↗
Feb 10, 2011
4
Titterton Lewis H Jr
Director
- POpen-market purchase+1,400,000
- POpen-market purchase+1,400,000
↗